Langsung ke konten

Bedah Kardiotorasik dan Vaskular (Anak)

Hasil Ekonomi

Safety and effects of two red blood cell transfusion strategies in pediatric cardiac surgery patients: a randomized controlled trial. (terbuka di window baru)

de Gast-Bakker DH, de Wilde RB, Hazekamp MG, Sojak V, Zwaginga JJ, Wolterbeek R, de Jonge E, Gesink-van der Veer BJ.

Sumber‎: Intensive Care Med 2013;39(11):2011-9.

Index‎: PubMed 23995984

DOI‎: 10.1007/s00134-013-3085-7

https://www.ncbi.nlm.nih.gov/pubmed/23995984 (terbuka di window baru)

Pediatric red blood cell transfusions increase resource use. (terbuka di window baru)

Goodman AM, Pollack MM, Patel KM, Luban NL.

Sumber‎: J Pediatr 2003;142(2):123-7.

Index‎: PubMed 12584531

DOI‎: 10.1067/mpd.2003.14

https://www.ncbi.nlm.nih.gov/pubmed/12584531 (terbuka di window baru)

Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (terbuka di window baru)

Miller BE, Tosone SR, Tam VK, Kanter KR, Guzzetta NA, Bailey JM, Levy JH.

Sumber‎: Ann Thorac Surg 1998;66(2):535-40; discussion 541.

Index‎: PubMed 9725399

https://www.ncbi.nlm.nih.gov/pubmed/9725399 (terbuka di window baru)

Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (terbuka di window baru)

Pasquali SK, Li JS, He X, Jacobs ML, O'Brien SM, Hall M, Jaquiss RD, Welke KF, Peterson ED, Shah SS, Jacobs JP.

Sumber‎: J Thorac Cardiovasc Surg 2012;143(3):550-7.

Index‎: PubMed 22264414

DOI‎: 10.1016/j.jtcvs.2011.06.048

https://www.ncbi.nlm.nih.gov/pubmed/22264414 (terbuka di window baru)